Orchard Therapeutics plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -2.98 | -100% |
| P/S |
|
6.76 | 33.75 | -79.98% |
|
|
| P/BV |
|
0.4803 | 4.82 | -90.03% |
|
|
| P/FCF |
|
-1.19 | 61 | -101.94% |
|
|
| Ev/Ebitda |
|
-4.56 | -22.17 | -79.42% |
|
|
| Ev/S |
|
1.69 | 22.56 | -92.51% |
|
|
| Ev/FCF |
|
-0.3908 | 68.75 | -100.57% |
|
|
| E/P |
|
-0.6511 | 0.0178 | -3763.28% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-115.65 | 4.98 | -2423.72% | -3962.23 | -97.08% |
| ROE |
|
-5.12 | 9.61 | -153.22% |
|
|
| ROA |
|
-2.91 | 0.3443 | -946.03% |
|
|
| ROIC |
|
-51.67 | 7.63 | -776.81% |
|
|
| ROS |
|
-333.9 | -25.17 | 1226.57% |
|
|
| ROCE |
|
-19.95 | 15.35 | -229.98% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-7.17 | -3.68 | 95.14% | -5.78 | +24.08% |
| Nеt Debt/Ebitda |
|
1.27 | -3.44 | -137% |
|
|
| Debt/Ratio |
|
0.2654 | 0.1985 | 33.72% |
|
|
| Debt/Equity |
|
0.3456 | 1.66 | -79.21% |
|
|
| Debt/Net Income |
|
-0.7968 | 10.32 | -107.72% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
773.56 | -56.89 | -1459.75% | ||
| Growth impulse Ebitda in 5 years |
|
-96.22 | -54.68 | 75.97% | ||
| Growth impulse Net Income in 5 years |
|
-55.37 | -58.33 | -5.07% | ||
| Growth impulse FCF in 5 years |
|
-44.63 | -49.48 | -9.8% | ||
| Growth impulse EPS in 5 years |
|
251.4 | -32.41 | -875.69% |
IP Score
3.75/10
